12-08-2017, 12:47 PM
The DOJ plate filling up fast will so much corruption to be uncovered in the wake of the last administration.
The Majority Staff Report concludes:
• Despite the clear legislative history of the 1993 NIH Revitalization Act, the executive branch across multiple administrations has failed to enforce the law’s safeguards.
• Since 2010, three companies - Advanced Bioscience Resources, Inc.; StemExpress, LLC; and Novogenix Laboratories, LLC (Novogenix has since gone out of business) - have paid affiliates of Planned Parenthood Federation of America to acquire aborted fetuses, and then sold the fetal tissue to their respective customers at substantially higher prices than their documented costs.
• The Planned Parenthood Federation of America (PPFA) initially had a policy in place to ensure its affiliates were complying with the law, but the affiliates failed to follow its fetal tissue reimbursement policy. When PPFA learned in 2011 of this situation, PPFA cancelled the policy rather than exercise oversight to bring the affiliates back into compliance. Thus, PPFA not only turned a blind eye to the affiliates’ violations of its fetal tissue policy, but also altered its own oversight procedures enabling those affiliates’ practices to continue unimpeded.
• The cost analyses provided by affiliates of Planned Parenthood Federation of America lack sufficient documentation and rely on unreasonably broad and vague claims of costs for “the transportation, implantation, processing, preservation, quality control or storage of” fetal tissue. Planned Parenthood attorneys acknowledge that the affiliates had failed to follow procedures put in place to ensure compliance with the law. In addition, the cost analyses were only performed long after the fact and at the insistence of the committee.
The full report details the long history of the controversy surrounding human fetal tissue research and the bipartisan legislative approach taken to resolve the issue at the time, as well as the subsequent lack of enforcement. As the report explains, “Support for the 1993 NIH Revitalization Act was premised on the idea that the ban on buying or selling fetal tissue would be a safeguard against the development for a market for human fetuses. Tragically, the executive branch has either failed or simply refused to enforce that safeguard. As a result, contrary to the intent of the law, companies have charged thousands of dollars for specimens removed from a single aborted fetus; they have claimed the fees they charged only recovered acceptable costs when they had not, in fact, conducted any analysis of their costs when setting the fees; and their post hoc accounting rationalizations invoked indirect and tenuously-related costs in an attempt to justify their fees.”
The report can be found here.
The referral can be found here.
http://www.breitbart.com/big-government/2017/12/07/justice-department-launches-federal-investigation-planned-parenthood/
https://www.grassley.senate.gov/news/news-releases/grassley-refers-planned-parenthood-fetal-tissue-procurement-organizations-fbi
The Majority Staff Report concludes:
• Despite the clear legislative history of the 1993 NIH Revitalization Act, the executive branch across multiple administrations has failed to enforce the law’s safeguards.
• Since 2010, three companies - Advanced Bioscience Resources, Inc.; StemExpress, LLC; and Novogenix Laboratories, LLC (Novogenix has since gone out of business) - have paid affiliates of Planned Parenthood Federation of America to acquire aborted fetuses, and then sold the fetal tissue to their respective customers at substantially higher prices than their documented costs.
• The Planned Parenthood Federation of America (PPFA) initially had a policy in place to ensure its affiliates were complying with the law, but the affiliates failed to follow its fetal tissue reimbursement policy. When PPFA learned in 2011 of this situation, PPFA cancelled the policy rather than exercise oversight to bring the affiliates back into compliance. Thus, PPFA not only turned a blind eye to the affiliates’ violations of its fetal tissue policy, but also altered its own oversight procedures enabling those affiliates’ practices to continue unimpeded.
• The cost analyses provided by affiliates of Planned Parenthood Federation of America lack sufficient documentation and rely on unreasonably broad and vague claims of costs for “the transportation, implantation, processing, preservation, quality control or storage of” fetal tissue. Planned Parenthood attorneys acknowledge that the affiliates had failed to follow procedures put in place to ensure compliance with the law. In addition, the cost analyses were only performed long after the fact and at the insistence of the committee.
The full report details the long history of the controversy surrounding human fetal tissue research and the bipartisan legislative approach taken to resolve the issue at the time, as well as the subsequent lack of enforcement. As the report explains, “Support for the 1993 NIH Revitalization Act was premised on the idea that the ban on buying or selling fetal tissue would be a safeguard against the development for a market for human fetuses. Tragically, the executive branch has either failed or simply refused to enforce that safeguard. As a result, contrary to the intent of the law, companies have charged thousands of dollars for specimens removed from a single aborted fetus; they have claimed the fees they charged only recovered acceptable costs when they had not, in fact, conducted any analysis of their costs when setting the fees; and their post hoc accounting rationalizations invoked indirect and tenuously-related costs in an attempt to justify their fees.”
The report can be found here.
The referral can be found here.
http://www.breitbart.com/big-government/2017/12/07/justice-department-launches-federal-investigation-planned-parenthood/
https://www.grassley.senate.gov/news/news-releases/grassley-refers-planned-parenthood-fetal-tissue-procurement-organizations-fbi
